Themis Medicare
75.29
+0.03(+0.04%)
Market Cap₹692.97 Cr
PE Ratio-39.82
IndustryHealthcare
Company Performance:
1D+0.04%
1M-16.62%
6M-41.89%
1Y-51.79%
5Y+155.57%
View Company Insightsright
More news about Themis Medicare
12Sept 25
Themis Medicare Declares Dividend, Appoints New Independent Director and Secretarial Auditor
Themis Medicare announced key decisions at its 55th AGM. The company declared a dividend of Rs 0.50 per share, appointed Ms. Neha Thakore as an Independent Woman Director for a five-year term, and selected M/s. SAV & Associates LLP as Secretarial Auditor. Shareholders approved financial statements, re-appointed Dr. Adam Demeter as director, ratified Cost Auditor remuneration, and approved commission for Non-Executive Directors.
 no imag found
04Aug 25
Themis Medicare Reports Q1 Net Loss of 142 Million Rupees Amid Revenue Decline
Themis Medicare, a pharmaceutical company, reported a consolidated net loss of ₹142.00 million in Q1, contrasting with a ₹247.00 million profit in the same quarter last year. Revenue decreased by 24.92% to ₹976.00 million from ₹1,300.00 million. EBITDA turned negative at ₹101.00 million loss, compared to a positive ₹292.00 million in the previous year's quarter.
 no imag found
20May 25
Themis Medicare Reports Q4 Revenue Decline and Net Loss
Themis Medicare's Q4 financial results show a significant downturn. The company reported a net loss of ₹96.60 million, contrasting with a profit of ₹66.40 million in the same quarter last year. Revenue decreased by 26.70% compared to the previous quarter. This marks a notable shift from the ₹5.20 million profit in the preceding quarter, indicating volatility in the company's financial performance.
 no imag found
Themis Medicare
75.29
+0.03
(+0.04%)
1 Year Returns:-51.79%
Industry Peers
Sun Pharmaceutical
1,777.10
(+1.87%)
Divis Laboratories
6,100.00
(+2.13%)
Torrent Pharmaceuticals
4,270.20
(+1.41%)
Dr Reddys Laboratories
1,298.90
(+1.91%)
Lupin
2,322.50
(+3.15%)
Cipla
1,256.40
(+1.39%)
Zydus Life Science
890.50
(+1.64%)
Mankind Pharma
2,000.00
(-0.04%)
Aurobindo Pharma
1,291.40
(+3.52%)
Alkem Laboratories
5,257.50
(+0.33%)